Page 38 - Lexaria Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lexaria Bioscience Corp.: Lexaria Strengthens Its International Patent Portfolio to 19 Patents Granted New patent granted in India bolsters worldwide patent coverage, adding to existing patents in the EU, the U.S., and Australia KELOWNA, BC / ACCESSWIRE / May 12, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces further expansion of its intellectual property portfolio with its first-ever patent granted in India. The patent is titled "Stable ready-to-drink beverage compositions comprising ...

(V)ia Regal Pink Grape Sparkler is the first product launched under Hill Avenue Cannabis brand. Toronto, Ontario--(Newsfile Corp. - May 12, 2021) - Hill Street Beverage Company Inc. (TSXV: BEER) ("Hill

(1) Lexaria Recently Announced Favorable Data on Its First Animal Study, As Well as the Commencement of Its First Human Clinical Study, Under Its 2021 Hypertension R&D Program KELOWNA, BC / ACCESSWIRE / May 7, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that CEO Chris Bunka is presenting at the Benzinga Global Small Cap Conference to be held on May 13-14, 2021. Complimentary investor registration can be accessed through the conference link below. Presentation date: Thursday, M...

Lexaria to Present at the Benzinga Global Small Cap Conference on May 13, 2021 at 3:50 p.m. ET ACCESSWIRE 07 May 2021, 23:05 GMT+10 Lexaria Recently Announced Favorable Data on Its First Animal Study, As Well as the Commencement of Its First Human Clinical Study, Under Its 2021 Hypertension R&D Program KELOWNA, BC / ACCESSWIRE / May 7, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the 'Company' or 'Lexaria'), a global innovator in drug delivery platforms, today announced that CEO Chris Bunka is presenting at the Benzinga Global Small Cap Conference to be held on May 13...

(1) Phoenix, Arizona--(Newsfile Corp. - May 7, 2021) - The Stock Day Podcast welcomed Lexaria Bioscience Corp. (NASDAQ: LEXX) ("the Company"), a company with a proprietary drug delivery technology, DehydraTECH, which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream. CEO of the Company, Chris Bunka, joined Stock Day host Everett Jolly. Jolly began the interview by commenting on a recent press release detailing the Company's involvement in the hypertension market. "What are your thoughts about your company and your valuation going forward?", asked Jolly. "The hype...